Comparative trial between sodium tetradecyl sulfate and glycerin in the treatment of telangiectatic leg veins

Dermatologic Surgery

Volumn 29, Issue 6, 2003, Pages 612-615

  Leach, Brian C ^a   Goldman, Mitchel P ^a   Sadick, Neil ^b  

^a Dermatology/Cosmetic Laser Associates   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLYCEROL; SCLEROSING AGENT; TETRADECYL SULFATE SODIUM;

ADULT; AGED; ARTICLE; CAPILLARY RESISTANCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EDEMA; FEMALE; FOLLOW UP; HUMAN; HYPERPIGMENTATION; INJECTION PAIN; LEG VEIN; PATIENT SATISFACTION; PRIORITY JOURNAL; SCLEROTHERAPY; SIDE EFFECT; TELANGIECTASIA; TIME SERIES ANALYSIS; TREATMENT OUTCOME;

ADULT; AGED; CRYOPROTECTIVE AGENTS; FEMALE; GLYCEROL; HUMANS; INJECTIONS, INTRALESIONAL; MIDDLE AGED; SCLEROSING SOLUTIONS; SODIUM TETRADECYL SULFATE; TELANGIECTASIS; TREATMENT OUTCOME; VARICOSE VEINS;

EID: 0038792647     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4725.2003.29148.x     Document Type: Article

References (21)

1. Goldman MP, Bergan JJ. Sclerotherapy Treatment of Varicose and Telangiectatic Leg Veins, 3rd ed. St. Louis: Mosby, 2001.
2. Reiner L. The activity of anionic surface active compounds in producing vascular obliteration. Proc Soc Exp Biol Med 1946;62:49.
3. Goldman MP. Treatment of varicose and telangiectatic leg veins: double-blind prospective comparative trial between aethoxyskerol and sotradecol. Dermatol Surg 2002;28:52-5.
4. National Institute for Occupational Safety and Health Glycerol: The Registry of Toxic Effects of Chemical Substances. July 2000, RTECS♯ MA8050000.
5. Frank MSB, Nahata MC, Hilty MD. Glycerol: a review of its pharmacology, pharmacokinetics, adverse reactions and clinical use. Pharmacotherapy 1981;1:147-60.
6. Jausion H, Carrot E, Ervais A. Une methode simple de phlebosclerose: la cure des varices par les injections de glycerine diluee. Bull Soc Fran Dermatol Syph 1931;38:171.
7. Martindale. The Extra Pharmacopoeia, 28th ed. London: The Pharmaceutical Press, 1982:706-7.
8. Hammarlund ER, Pedersen-Bjergaard L. Hemolysis of erythrocytes in various iso-osmotic solutions. J Pharm Sci 1961;50:24.
9. Jausion H. Glycerine chromee et sclerose des ectasies veineuses. La Presse Med 1933;53:1061.
10. Jausion H, Medioni G, Pecker A, Gozlan W. La sclerose des varices et des hemorrhoids par le glycerine chromee. Bull Memoires Soc Med Hospitaux Paris 1932;587.
11. Ouvry PA. Telangiectasia and sclerotherapy. J Dermatol Surg Oncol 1989;15:177-81.
12. Sclermo Product Information. France: Laboratories E. Bouteille, 1987.
13. Tourtellotte WW, Reinglass JL, Newkirk TA. Cerebral dehydrating action of glycerol. I. Historical aspects with emphasis on the toxicity and intravenous administration. Clin Pharmacol Ther 1972;13:159-71.
14. Borchgrevink CF, Havel JR. Transport of glycerol in human blood. Proc Soc Exp Biol Med 1969;113:946-8.
15. Holst EJ. Glycerol oxidation in the animal organism. Acta Physiol Scand 1944;7:69-79.
16. Nahata MC, Kerzner B, McClung HJ, et al. Variations in glycerol kinetics in Reye's syndrome. Clin Pharmacol Ther 1981;29:782-7.
17. Zilversmit DB, McCandless EL. Fate of intravenously administered glycerol. Proc Soc Exp Biol Med 1957;95:755-7.
18. Kruhoffer P, Nissen OI. Handling of glycerol in kidney. Acta Physiol Scand 1963;59:284-94.
19. Sears ES. Nonketotic hyperosmolar hyperglycemia during glycerol therapy for cerebral edema. Neurology 1976;26:89-94.
20. Virno M, Bucci MG, Pecori-Giraldi J, et al. Intravenous glycerol-vitamin C (sodium salt), as osmotic agents to reduce intraocular pressure. Am J Ophthalmol 1966;62:824-33.
21. Martin DE, Goldman MP. A comparison of sclerosing agents: clinical and histologic effects of intravascular sodium tetradecyl sulfate and chromated glycerin in the dorsal rabbit ear vein. J Dematol Surg Oncol 1990;16:18-22.